Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Anxiety Disorders × Dronabinol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 4 Vomiting 3 Nausea 3 Pancreatic Neoplasms 2 Neoplasms 2 Breast Neoplasms 2 Parasomnias 1 Marijuana Abuse 1 Malnutrition 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Cancer Pain 1 Brain Neoplasms 1 Anxiety Disorders 1

Interventions

Music Therapy 13 Therapeutics 11 Psychiatric Rehabilitation 11 Cognitive Behavioral Therapy 11 Surveys and Questionnaires 9 Standard of Care 8 Methods 8 Educational Status 8 Early Intervention, Educational 8 Psilocybin 6 Ketamine 6 Hypnosis 6 Control Groups 6 Acupuncture Therapy 6 Mindfulness 5 Art Therapy 5 Aromatherapy 5 Saline Solution 4 Mindfulness-Based Stress Reduction 4 Mindfulness-Based Cognitive Therapy 4 Interviews as Topic 4 Esketamine 4 Counseling 4 Caregivers 4 Behavior Therapy 4 Autogenic Training 4 Yoga 3 Weights and Measures 3 Touch 3 Therapeutic Touch 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03948074 2025-09-10

CAFCARS

British Columbia Cancer Agency

Phase 2 Completed

Anxiety Disorders, Nausea, Pain, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡